|
Delayed
Bombay S.E.
08:23:28 16/07/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2,412.25 INR | -3.73% |
|
-.--% | +32.51% |
| Market Cap | 387B 4.04B 3.5B 3.3B 3B 5.62B 5.66B 39.46B 15.21B 196B 15.18B 14.84B 625B | P/E 2027 * |
43.3x | P/E 2028 * | 33x |
|---|---|---|---|---|---|
| Enterprise Value | 387B 4.04B 3.5B 3.3B 3B 5.62B 5.66B 39.46B 15.21B 196B 15.18B 14.84B 625B | EV / Sales 2027 * |
8.14x | EV / Sales 2028 * | 7.12x |
| Free-Float |
-
| Yield 2027 * |
0.72% | Yield 2028 * | 0.86% |
Last Transcript: JBCHEMICAPAR
| 1 day | -3.73% | ||
| 3 months | +6.67% | ||
| 6 months | +13.69% | ||
| Current year | +32.51% |
| Current year | 1,777.05 |  | 2,509.4 |
| 1 year | 1,603.05 | | 2,509.4 |
| 3 years | 1,246.05 | | 2,509.4 |
| 5 years | 669.52 | | 2,509.4 |
| 10 years | 118 | | 2,509.4 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/9/25 | Sell | Chief Executive Officer | 24,785 | 0.0159% | ||
| 22/9/25 | Sell | Chief Executive Officer | 19,312 | 0.0124% | ||
| 15/9/25 | Sell | Chief Executive Officer | 965 | 0.0006% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 47.6B 497M 430M 406M 368M 691M 696M 4.85B 1.87B 24.15B 1.87B 1.82B 76.78B | 54.41B 568M 492M 464M 421M 790M 796M 5.54B 2.14B 27.6B 2.13B 2.09B 87.75B |
| Net income | 9B 93.87M 81.34M 76.76M 69.64M 131M 132M 917M 353M 4.56B 353M 345M 14.51B | 11.85B 124M 107M 101M 91.75M 172M 173M 1.21B 465M 6.01B 465M 454M 19.12B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JBCHEPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
